Clinical Impact of Cytochrome P450 2C19 Genotype on the Treatment of Invasive Aspergillosis under Routine Therapeutic Drug Monitoring of Voriconazole in a Korean Population

BACKGROUND: Genetic polymorphisms of cytochrome P450 enzymes, especially CYP2C19 influence voriconazole pharmacokinetics. However, the impact of CYP2C19 genetic polymorphisms on the therapeutic efficacy and toxicity of voriconazole therapy are not well established. MATERIALS AND METHODS: In this pro...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Si-Hyun, Lee, Dong-Gun, Kwon, Jae-Cheol, Lee, Hyo-Jin, Cho, Sung-Yeon, Park, Chulmin, Kwon, Eun-Young, Park, Sun Hee, Choi, Su-Mi, Choi, Jung-Hyun, Yoo, Jin-Hong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Society of Infectious Diseases and Korean Society for Chemotherapy 2013
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3902809/
https://www.ncbi.nlm.nih.gov/pubmed/24475354
http://dx.doi.org/10.3947/ic.2013.45.4.406

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3902809/
https://www.ncbi.nlm.nih.gov/pubmed/24475354
http://dx.doi.org/10.3947/ic.2013.45.4.406

Ejemplares similares